Hormone-regulated transcriptomes: Lessons learned from estrogen signaling pathways in breast cancer cells

Molecular and Cellular Endocrinology

Volumn 382, Issue 1, 2014, Pages 652-664

  Hah, Nasun ^a   Kraus, W Lee ^b,c  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Breast cancer cells; Estrogen; Estrogen receptor; GRO seq; Non coding RNA; Transcriptome

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; RNA POLYMERASE; TRANSCRIPTOME; UNTRANSLATED RNA;

ARTICLE; BIOTECHNOLOGY; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GENOME; GENOMICS; HIGH THROUGHPUT SEQUENCING; HORMONAL REGULATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

17Β-ESTRADIOL; BREAST CANCER CELLS; CHIP; CHROMATIN IMMUNOPRECIPITATION; E2; ENHANCER RNA; ERBS; ERNA; ERΑ; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR Α BINDING SITE; GLOBAL NUCLEAR RUN-ON AND SEQUENCING; GRO-SEQ; HIDDEN MARKOV MODEL LNCRNA, LONG NON-CODING RNAS; HMM; MESSENGER RNA; MRNA; NON-CODING RNA; POL (I, II, III); RIBOSOMAL RNA; RNA POLYMERASE (I, II, III); RRNA; SELECTIVE ESTROGEN-RECEPTOR MODULATOR; SERM; TRANSCRIPTOME; TRANSFER RNA; TRNA;

BREAST NEOPLASMS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84888363048     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.06.021     Document Type: Article

References (90)

1. Adelman K., Lis J.T. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat. Rev. Genet. 2012, 13:720-731.
2. Aiyar S.E., Sun J.L., Blair A.L., Moskaluk C.A., Lu Y.Z., Ye Q.N., Yamaguchi Y., Mukherjee A., Ren D.M., Handa H., Li R. Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. Genes. Dev. 2004, 18:2134-2146.
3. Askarian-Amiri M.E., Crawford J., French J.D., Smart C.E., Smith M.A., Clark M.B., Ru K., Mercer T.R., Thompson E.R., Lakhani S.R., Vargas A.C., Campbell I.G., Brown M.A., Dinger M.E., Mattick J.S. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA 2011, 17:878-891.
4. Bai Z., Gust R. Breast cancer, estrogen receptor and ligands. Arch. Pharm. (Weinheim) 2009, 342:133-149.
5. Berry M., Nunez A.M., Chambon P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. USA 1989, 86:1218-1222.
6. Bickel K.S., Morris D.R. Silencing the transcriptome's dark matter: mechanisms for suppressing translation of intergenic transcripts. Mol. Cell 2006, 22:309-316.
7. Bjornstrom L., Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 2005, 19:833-842.
8. Boettiger A.N., Levine M. Synchronous and stochastic patterns of gene activation in the Drosophila embryo. Science 2009, 325:471-473.
9. Bulger M., Groudine M. Functional and mechanistic diversity of distal transcription enhancers. Cell 2011, 144:327-339.
10. Cadenas C., Bolt H.M. Estrogen receptors in human disease. Arch. Toxicol. 2012, 86:1489-1490.
11. Carroll J.S., Brown M. Estrogen receptor target gene: an evolving concept. Mol. Endocrinol. 2006, 20:1707-1714.
12. Carroll R.S., Brown M., Zhang J., DiRenzo J., Font De Mora J., Black P.M. Expression of a subset of steroid receptor cofactors is associated with progesterone receptor expression in meningiomas. Clin. Cancer Res. 2000, 6:3570-3575.
13. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W., Hestermann E.V., Geistlinger T.R., Fox E.A., Silver P.A., Brown M. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43.
14. Carroll J.S., Meyer C.A., Song J., Li W., Geistlinger T.R., Eeckhoute J., Brodsky A.S., Keeton E.K., Fertuck K.C., Hall G.F., Wang Q., Bekiranov S., Sementchenko V., Fox E.A., Silver P.A., Gingeras T.R., Liu X.S., Brown M. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 2006, 38:1289-1297.
15. Cazzaniga M., Bonanni B. Breast cancer chemoprevention: old and new approaches. J. Biomed. Biotechnol. 2012, 2012:985620.
16. Cheung E., Kraus W.L. Genomic analyses of hormone signaling and gene regulation. Annu. Rev. Physiol. 2010, 72:191-218.
17. Cheung E., Schwabish M.A., Kraus W.L. Chromatin exposes intrinsic differences in the transcriptional activities of estrogen receptors alpha and beta. EMBO J. 2003, 22:600-611.
18. Core L.J., Lis J.T. Transcription regulation through promoter-proximal pausing of RNA polymerase II. Science 2008, 319:1791-1792.
19. Core L.J., Waterfall J.J., Lis J.T. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 2008, 322:1845-1848.
20. Creighton C.J., Cordero K.E., Larios J.M., Miller R.S., Johnson M.D., Chinnaiyan A.M., Lippman M.E., Rae J.M. Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors. Genome Biol. 2006, 7:R28.
21. Danko C.G., Hah N., Luo X., Martins A.L., Core L., Lis J.T., Siepel A., Kraus W.L. Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells. Mol. Cell 2013, 50:212-222.
22. De Santa F., Barozzi I., Mietton F., Ghisletti S., Polletti S., Tusi B.K., Muller H., Ragoussis J., Wei C.L., Natoli G. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol. 2010, 8:e1000384.
23. Deroo B.J., Korach K.S. Estrogen receptors and human disease. J. Clin. Invest. 2006, 116:561-570.
24. Djebali S., Davis C.A., Merkel A., Dobin A., Lassmann T., Mortazavi A., Tanzer A., Lagarde J., Lin W., Schlesinger F., Xue C., Marinov G.K., Khatun J., Williams B.A., Zaleski C., Rozowsky J., Roder M., Kokocinski F., Abdelhamid R.F., Alioto T., Antoshechkin I., Baer M.T., Bar N.S., Batut P., Bell K., Bell I., Chakrabortty S., Chen X., Chrast J., Curado J., Derrien T., Drenkow J., Dumais E., Dumais J., Duttagupta R., Falconnet E., Fastuca M., Fejes-Toth K., Ferreira P., Foissac S., Fullwood M.J., Gao H., Gonzalez D., Gordon A., Gunawardena H., Howald C., Jha S., Johnson R., Kapranov P., King B., Kingswood C., Luo O.J., Park E., Persaud K., Preall J.B., Ribeca P., Risk B., Robyr D., Sammeth M., Schaffer L., See L.H., Shahab A., Skancke J., Suzuki A.M., Takahashi H., Tilgner H., Trout D., Walters N., Wang H., Wrobel J., Yu Y., Ruan X., Hayashizaki Y., Harrow J., Gerstein M., Hubbard T., Reymond A., Antonarakis S.E., Hannon G., Giddings M.C., Ruan Y., Wold B., Carninci P., Guigo R., Gingeras T.R. Landscape of transcription in human cells. Nature 2012, 489:101-108.
25. Escoubet-Lozach L., Benner C., Kaikkonen M.U., Lozach J., Heinz S., Spann N.J., Crotti A., Stender J., Ghisletti S., Reichart D., Cheng C.S., Luna R., Ludka C., Sasik R., Garcia-Bassets I., Hoffmann A., Subramaniam S., Hardiman G., Rosenfeld M.G., Glass C.K. Mechanisms establishing TLR4-responsive activation states of inflammatory response genes. PLoS Genet. 2011, 7:e1002401.
26. Fullwood M.J., Liu M.H., Pan Y.F., Liu J., Xu H., Mohamed Y.B., Orlov Y.L., Velkov S., Ho A., Mei P.H., Chew E.G., Huang P.Y., Welboren W.J., Han Y., Ooi H.S., Ariyaratne P.N., Vega V.B., Luo Y., Tan P.Y., Choy P.Y., Wansa K.D., Zhao B., Lim K.S., Leow S.C., Yow J.S., Joseph R., Li H., Desai K.V., Thomsen J.S., Lee Y.K., Karuturi R.K., Herve T., Bourque G., Stunnenberg H.G., Ruan X., Cacheux-Rataboul V., Sung W.K., Liu E.T., Wei C.L., Cheung E., Ruan Y. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009, 462:58-64.
27. Gadad S.S., Sun M., Kraus W.L. Identification and functional characterization of estrogen-regulated long noncoding RNAs in breast cancer cells: from genomics to molecular and cellular biology. Endocr. Rev. 2012, 33:SUN-565.
28. Ginger M.R., Shore A.N., Contreras A., Rijnkels M., Miller J., Gonzalez-Rimbau M.F., Rosen J.M. A noncoding RNA is a potential marker of cell fate during mammary gland development. Proc. Natl. Acad. Sci. USA 2006, 103:5781-5786.
29. Hah N., Danko C.G., Core L., Waterfall J.J., Siepel A., Lis J.T., Kraus W.L. A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell 2011, 145:622-634.
30. Hah N., Murakami S., Nagari A., Danko C., Kraus W.L. Enhancer transcripts mark active estrogen receptor binding sites. Genome Res. 2013, 23. http://dx.doi.org/10.1101/gr.152306.112.
31. Hall J.M., Couse J.F., Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 2001, 276:36869-36872.
32. Hammes S.R., Levin E.R. Extranuclear steroid receptors: nature and actions. Endocr. Rev. 2007, 28:726-741.
33. Hammes S.R., Levin E.R. Minireview: recent advances in extranuclear steroid receptor actions. Endocrinology 2011, 152:4489-4495.
34. Harrington W.R., Sheng S., Barnett D.H., Petz L.N., Katzenellenbogen J.A., Katzenellenbogen B.S. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol. Cell. Endocrinol. 2003, 206:13-22.
35. Heidemann M., Hintermair C., Voss K., Eick D. Dynamic phosphorylation patterns of RNA polymerase II CTD during transcription. Biochim. Biophys. Acta 2013, 1829:55-62.
36. Heldring N., Isaacs G.D., Diehl A.G., Sun M., Cheung E., Ranish J.A., Kraus W.L. Multiple sequence-specific DNA-binding proteins mediate estrogen receptor signaling through a tethering pathway. Mol. Endocrinol. 2011, 25:564-574.
37. Herschman H.R. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 1991, 60:281-319.
38. Hsu P.Y., Hsu H.K., Singer G.A., Yan P.S., Rodriguez B.A., Liu J.C., Weng Y.I., Deatherage D.E., Chen Z., Pereira J.S., Lopez R., Russo J., Wang Q., Lamartiniere C.A., Nephew K.P., Huang T.H. Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping. Genome Res. 2010, 20:733-744.
39. Hurtado A., Holmes K.A., Ross-Innes C.S., Schmidt D., Carroll J.S. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet. 2011, 43:27-33.
40. Katzenellenbogen B.S., Katzenellenbogen J.A. Estrogen receptor transcription and transactivation: estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res. 2000, 2:335-344.
41. Kelly V.R., Xu B., Kuick R., Koenig R.J., Hammer G.D. Dax1 up-regulates Oct4 expression in mouse embryonic stem cells via LRH-1 and SRA. Mol. Endocrinol. 2010, 24:2281-2291.
42. Kim T.K., Hemberg M., Gray J.M., Costa A.M., Bear D.M., Wu J., Harmin D.A., Laptewicz M., Barbara-Haley K., Kuersten S., Markenscoff-Papadimitriou E., Kuhl D., Bito H., Worley P.F., Kreiman G., Greenberg M.E. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010, 465:182-187.
43. Kininis M., Kraus W.L. A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis. Nucl. Recept. Signal. 2008, 6:e005.
44. Kininis M., Isaacs G.D., Core L.J., Hah N., Kraus W.L. Postrecruitment regulation of RNA polymerase II directs rapid signaling responses at the promoters of estrogen target genes. Mol. Cell. Biol. 2009, 29:1123-1133.
45. Kino T., Hurt D.E., Ichijo T., Nader N., Chrousos G.P. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal 2010, 3:ra8.
46. Kolovos P., Knoch T.A., Grosveld F.G., Cook P.R., Papantonis A. Enhancers and silencers: an integrated and simple model for their function. Epigenetics Chromatin 2012, 5:1.
47. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
48. Kumar V., Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 1988, 55:145-156.
49. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., Webb P. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 2000, 74:311-317.
50. Lai F., Orom U.A., Cesaroni M., Beringer M., Taatjes D.J., Blobel G.A., Shiekhattar R. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 2013, 494:497-501.
51. Lam M.T., Cho H., Lesch H.P., Gosselin D., Heinz S., Tanaka-Oishi Y., Benner C., Kaikkonen M.U., Kim A.S., Kosaka M., Lee C.Y., Watt A., Grossman T.R., Rosenfeld M.G., Evans R.M., Glass C.K. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 2013.
52. Lee J.T. Epigenetic regulation by long noncoding RNAs. Science 2012, 338:1435-1439.
53. Levin E.R. Membrane oestrogen receptor alpha signalling to cell functions. J. Physiol. 2009, 587:5019-5023.
54. Li G., Ruan X., Auerbach R.K., Sandhu K.S., Zheng M., Wang P., Poh H.M., Goh Y., Lim J., Zhang J., Sim H.S., Peh S.Q., Mulawadi F.H., Ong C.T., Orlov Y.L., Hong S., Zhang Z., Landt S., Raha D., Euskirchen G., Wei C.L., Ge W., Wang H., Davis C., Fisher-Aylor K.I., Mortazavi A., Gerstein M., Gingeras T., Wold B., Sun Y., Fullwood M.J., Cheung E., Liu E., Sung W.K., Snyder M., Ruan Y. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 2012, 148:84-98.
55. Li W., Notani D., Ma Q., Tanasa B., Nunez E., Chen A.Y., Merkurjev D., Zhang J., Ohgi K., Song X., Oh S., Kim H.S., Glass C.K., Rosenfeld M.G. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 2013.
56. Lin C.Y., Strom A., Vega V.B., Kong S.L., Yeo A.L., Thomsen J.S., Chan W.C., Doray B., Bangarusamy D.K., Ramasamy A., Vergara L.A., Tang S., Chong A., Bajic V.B., Miller L.D., Gustafsson J.A., Liu E.T. Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biol. 2004, 5:R66.
57. Lin C.Y., Vega V.B., Thomsen J.S., Zhang T., Kong S.L., Xie M., Chiu K.P., Lipovich L., Barnett D.H., Stossi F., Yeo A., George J., Kuznetsov V.A., Lee Y.K., Charn T.H., Palanisamy N., Miller L.D., Cheung E., Katzenellenbogen B.S., Ruan Y., Bourque G., Wei C.L., Liu E.T. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet. 2007, 3:e87.
58. Melo C.A., Drost J., Wijchers P.J., van de Werken H., de Wit E., Oude Vrielink J.A., Elkon R., Melo S.A., Leveille N., Kalluri R., de Laat W., Agami R. ERNAs are required for p53-dependent enhancer activity and gene transcription. Mol. Cell 2013, 49:524-535.
59. Mercer T.R., Mattick J.S. Structure and function of long noncoding RNAs in epigenetic regulation. Nat. Struct. Mol. Biol. 2013, 20:300-307.
60. Natoli G., Andrau J.C. Noncoding transcription at enhancers: general principles and functional models. Annu. Rev. Genet. 2012, 46:1-19.
61. Ong C.T., Corces V.G. Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat. Rev. Genet. 2011, 12:283-293.
62. Orom U.A., Shiekhattar R. Noncoding RNAs and enhancers: complications of a long-distance relationship. Trends Genet. 2011, 27:433-439.
63. Orom U.A., Shiekhattar R. Long non-coding RNAs and enhancers. Curr. Opin. Genet. Dev. 2011, 21:194-198.
64. Osborne C.K., Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J. Clin. Oncol. 2005, 23:1616-1622.
65. Pan Y.F., Wansa K.D., Liu M.H., Zhao B., Hong S.Z., Tan P.Y., Lim K.S., Bourque G., Liu E.T., Cheung E. Regulation of estrogen receptor-mediated long range transcription via evolutionarily conserved distal response elements. J. Biol. Chem. 2008, 283:32977-32988.
66. Pearce S.T., Jordan V.C. The biological role of estrogen receptors alpha and beta in cancer. Crit. Rev. Oncol. Hematol. 2004, 50:3-22.
67. Pfaffl M.W., Lange I.G., Daxenberger A., Meyer H.H. Tissue-specific expression pattern of estrogen receptors (ER): quantification of ER alpha and ER beta mRNA with real-time RT-PCR. APMIS 2001, 109:345-355.
68. Platet N., Cathiard A.M., Gleizes M., Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit. Rev. Oncol. Hematol. 2004, 51:55-67.
69. Prall O.W., Rogan E.M., Sutherland R.L. Estrogen regulation of cell cycle progression in breast cancer cells. J. Steroid Biochem. Mol. Biol. 1998, 65:169-174.
70. Rinn J.L., Chang H.Y. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 2012, 81:145-166.
71. Rochefort H., Platet N., Hayashido Y., Derocq D., Lucas A., Cunat S., Garcia M. Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview. J. Steroid Biochem. Mol. Biol. 1998, 65:163-168.
72. Seila A.C., Core L.J., Lis J.T., Sharp P.A. Divergent transcription: a new feature of active promoters. Cell Cycle 2009, 8:2557-2564.
73. Shore A.N., Herschkowitz J.I., Rosen J.M. Noncoding RNAs involved in mammary gland development and tumorigenesis: there's a long way to go. J. Mammary Gland Biol. Neoplasia 2012, 17:43-58.
74. Sigova A.A., Mullen A.C., Molinie B., Gupta S., Orlando D.A., Guenther M.G., Almada A.E., Lin C., Sharp P.A., Giallourakis C.C., Young R.A. Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells. Proc. Natl. Acad. Sci. USA 2013, 110:2876-2881.
75. Sinicropi D., Qu K., Collin F., Crager M., Liu M.L., Pelham R.J., Pho M., Rossi A.D., Jeong J., Scott A., Ambannavar R., Zheng C., Mena R., Esteban J., Stephans J., Morlan J., Baker J. Whole transcriptome RNA-Seq analysis of breast cancer recurrence risk using formalin-fixed paraffin-embedded tumor tissue. PLoS One 2012, 7:e40092.
76. Spizzo R., Almeida M.I., Colombatti A., Calin G.A. Long non-coding RNAs and cancer: a new frontier of translational research?. Oncogene 2012, 31:4577-4587.
77. Stender J.D., Kim K., Charn T.H., Komm B., Chang K.C., Kraus W.L., Benner C., Glass C.K., Katzenellenbogen B.S. Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation. Mol. Cell. Biol. 2010, 30:3943-3955.
78. Sun M., Danko G.G., Gadad S.S., Hah N., Kraus W.L. Characterization of estrogen-regulated non-coding RNAs. Endocr. Rev. 2011, 32. (OR14-2).
79. Sun L., Goff L.A., Trapnell C., Alexander R., Lo K.A., Hacisuleyman E., Sauvageau M., Tazon-Vega B., Kelley D.R., Hendrickson D.G., Yuan B., Kellis M., Lodish H.F., Rinn J.L. Long noncoding RNAs regulate adipogenesis. Proc. Natl. Acad. Sci. USA 2013, 110:3387-3392.
80. Tan S.K., Lin Z.H., Chang C.W., Varang V., Chng K.R., Pan Y.F., Yong E.L., Sung W.K., Cheung E. AP-2gamma regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription. EMBO J. 2011, 30:2569-2581.
81. Wang Z., Gerstein M., Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 2009, 10:57-63.
82. Wang D., Garcia-Bassets I., Benner C., Li W., Su X., Zhou Y., Qiu J., Liu W., Kaikkonen M.U., Ohgi K.A., Glass C.K., Rosenfeld M.G., Fu X.D. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 2011, 474:390-394.
83. Wapinski O., Chang H.Y. Long noncoding RNAs and human disease. Trends Cell Biol. 2011, 21:354-361.
84. Warner M., Nilsson S., Gustafsson J.A. The estrogen receptor family. Curr. Opin. Obstet. Gynecol. 1999, 11:249-254.
85. Welboren W.J., van Driel M.A., Janssen-Megens E.M., van Heeringen S.J., Sweep F.C., Span P.N., Stunnenberg H.G. ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J. 2009, 28:1418-1428.
86. Welboren W.J., Sweep F.C., Span P.N., Stunnenberg H.G. Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated?. Endocr. Relat. Cancer 2009, 16:1073-1089.
87. Winkles J.A. Serum- and polypeptide growth factor-inducible gene expression in mouse fibroblasts. Prog. Nucleic. Acid Res. Mol. Biol. 1998, 58:41-78.
88. Xu B., Gerin I., Miao H., Vu-Phan D., Johnson C.N., Xu R., Chen X.W., Cawthorn W.P., MacDougald O.A., Koenig R.J. Multiple roles for the non-coding RNA SRA in regulation of adipogenesis and insulin sensitivity. PLoS One 2010, 5:e14199.
89. Yamaga R., Ikeda K., Horie-Inoue K., Ouchi Y., Suzuki Y., Inoue S. RNA sequencing of MCF-7 breast cancer cells identifies novel estrogen-responsive genes with functional estrogen receptor-binding sites in the vicinity of their transcription start sites. Horm. Cancer 2013, 10.1007/s12672-013-0140-3.
90. Yan B., Wang Z. Long noncoding RNA: its physiological and pathological roles. DNA Cell Biol. 2012, 31(Suppl 1):S34-S41.